Cargando…
Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy
The Hedgehog/Glioma-associated oncogene homolog (HH/GLI) signaling pathway regulates self-renewal of rare and highly malignant cancer stem cells (CSC), which have been shown to account for the initiation and maintenance of tumor growth as well as for drug resistance, metastatic spread and relapse. E...
Autores principales: | Peer, Elisabeth, Tesanovic, Suzana, Aberger, Fritz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520835/ https://www.ncbi.nlm.nih.gov/pubmed/30991683 http://dx.doi.org/10.3390/cancers11040538 |
Ejemplares similares
-
Hedgehog/GLI signaling in hematopoietic development and acute myeloid leukemia—From bench to bedside
por: Tesanovic, Suzana, et al.
Publicado: (2022) -
Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC‐202 blocks oncogenic hedgehog‐GLI signaling and overcomes smoothened inhibitor resistance
por: Gruber, Wolfgang, et al.
Publicado: (2017) -
Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications
por: Grund-Gröschke, Sandra, et al.
Publicado: (2019) -
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
por: Aberger, Fritz, et al.
Publicado: (2017) -
From inflammation to gastric cancer – the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases
por: Wessler, Silja, et al.
Publicado: (2017)